Merck is buying Cidara Therapeutics for $9.2B, picking up an experimental flu therapy as it looks to broaden its pipeline.

Merck will acquire Cidara Therapeutics in a nearly $9.2 billion deal, the companies said on Friday, gaining access to an experimental drug for flu prevention.

Nearly $4.9 million was authorized to finance nearly a dozen contracts at the county commissioner’s sole November meeting.

Nearly two dozen babies in 13 states have been sickened in a growing outbreak of infantile botulism linked to recalled ...

The Federal Drug Administration, Center For Disease Control and Prevention, the California Department of Public Health, the ...

Next year, a multidisciplinary team will begin reviewing fatal overdose cases, examining people's whole lives to find ...

On World Diabetes Day, Sanofi is celebrating an approval recommendation in the EU for Teizeild, a first-in-class drug ...

Eli Lilly and Novo Nordisk’s competition in weight-loss drugs has affected thousands of jobs between Charlotte and Raleigh. Who is winning?

All the cases involve babies who have consumed ByHeart formula since August, and the number of affected infants has risen to ...